- Home
- TNDM
TNDM
Tandem Diabetes Care Inc.
as 04-18-2025 1:44pm EST
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Diego |
| Market Cap: | N/A | IPO Year: | 2013 |
| Target Price: | $44.44 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.75 - $53.69 | Next Earning Date: | 04-30-2025 |
| Revenue: | $940,203,000 | Revenue Growth: | 25.74% |
| Revenue Growth (this year): | 8.59% | Revenue Growth (next year): | 10.87% |
Stock Insider Trading Activity of Tandem Diabetes Care Inc. (TNDM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kyrillos Jean-Claude | TNDM | EVP & Chief Operating Officer | Mar 7 '25 | Buy | $18.12 | 10,538 | $190,966.47 | 10,538 |
Latest Tandem Diabetes Care Inc. News
TNDM Breaking Stock News: Dive into TNDM Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Reasons to Hold TNDM Stock in Your Portfolio for Now
Argus Research
3 days ago
TNDM: Raising target price to $19.00
MT Newswires
4 days ago
RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating
StockStory
4 days ago
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Motley Fool
7 days ago
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
Simply Wall St.
8 days ago
3 Undervalued Small Caps With Recent Insider Activity Across Regions
Zacks
9 days ago
Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?
MT Newswires
9 days ago
Mizuho Initiates Tandem Diabetes Care at Neutral With $20 Price Target
Compare TNDM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNDM Tandem Diabetes Care Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.